If this email is not displaying properly, please View as Webpage
PCSS Expands MAT Implementation Pilot Project
After successfully implementing a comprehensive opioid use disorder treatment plan using medication assisted treatment in five pilot healthcare systems, PCSS plans to add at least two more sites to its scope of work. Two sites have been chosen—Stony Brook Medicine in New York and Greenville Health System in South Carolina—and other sites may be added. In the initial five sites, PCSS clinical experts worked with local champions and multi-disciplinary teams in New Hampshire, Pennsylvania, Virginia, North Carolina, and Maryland to address challenges and barriers to MAT treatment in each system. 
Learn more about the implementation program, as well as lessons learned, here.
PCSS Participating in FDA Public Workshop Exploring
Expanding Access to Opioid Use Disorder Treatment
Date: Sept. 20, 2018
Location: National Press Club | 529 14th Street NW, Floor 13 | Washington, DC 20045
Time: 9:00 am - 4:15 pm
Registration: Use this link to register to attend in person or via webcast

The U.S. Food and Drug Administration (FDA) and the Duke Margolis Center for Health Policy will convene a public workshop, Expanding Access to Effective Treatment for Opioid Use Disorder: Provider Perspectives on Reducing Barriers to Evidence-Based Care. Discussions with practitioners and clinical experts will include evidence-based approaches to OUD treatment, addressing current barriers to access for effective pharmacotherapies, and opportunities to reduce stigma and increase access to OUD treatment. 
PCSS Trainings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
International Nurses Society on Addictions Archived Webinar
Treatment of Pain in Patients with Substance Use Disorder
Webinar description: This webinar will cover material on chronic and acute pain in patients with substance use disorders. The differences between chronic and acute pain will be described.  [Learn more]
Of Interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ACEP Free Webinar: E-QUAL Opioids Wave I – Harm Reduction
The purpose of this E-QUAL Opioid Wave I webinar is to describe harm reduction strategies including developing naloxone distribution programs and teaching IVD users to inject safely. This webinar provides up to date education on the latest ED quality improvement requirements in the diagnosis, prescribing, treatment, clinical skills and practice transformation innovations necessary for the practice of emergency medicine that relate to opioids care. [ Register ]
Free Management of Acute Pain Tool Now Available
The American College of Emergency Physicians has released a new tool that provides information on a variety of topics involving pain management. The tool includes information on:

  • Forearm Nerve Block
  • IA posterior Shoulder Inj.
  • Ketamine for Acute Pain
  • Nitrous Oxide
  • Trigger Point Injections
  • And others

[ View tool ]
FDA Issues Safety Recommendations for
First Responders Encountering Fentanyl
The increased prevalence of fentanyl has spurred the FDA into issuing safety recommendations to first responders to protect them from exposure. The Fentanyl Safety Recommendations for First Responders provide first responders with unified, scientific, evidence-based recommendations to protect themselves when the presence of fentanyl is suspected during the course of their daily activities such as responding to overdose calls, conducting traffic stops, arrests, and searches.
News and Studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
New England Journal of Medicine

British Journal of Medicine


Drug & Alcohol Dependence

The American Journal of Obstetrics & Gynecology

Journal of Adolescent Health

Pew Charitable Trusts

The American Journal on Addictions

Journal of Substance Abuse Treatment

Annals of Family Medicine
PCSS Online Brochure. Please share this link with colleagues: https://goo.gl/G1ay6H
Funding for this initiative was made possible (in part) by grant nos. 5H79TI025595-03, 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.